Patents by Inventor Neil Smith

Neil Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12637465
    Abstract: The present invention relates to new pharmaceutical salts and/or co-crystals of sepiapterin which exhibit improved properties. In particular, the invention relates to salts of sepiapterin with improved stability. The invention also relates to pharmaceutical compositions including a pharmaceutically effective amount of one or more salts and/or co-crystals of sepiapterin, as well as methods of treating tetrahydrobiopterin-related disorders including administration of a sepiapterin salt and/or co-crystal of the invention to a subject in need thereof.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: May 26, 2026
    Assignee: PTC Therapeutics MP, Inc.
    Inventors: Daniel E. Levy, Neil Smith, Jonathan Reis, Hiroshi Yoshino, Taichi Komoda, Yuichi Shiro, Shunichi Murata, Takayoshi Matsumoto, Kaito Kishimoto
  • Publication number: 20260091037
    Abstract: The present invention features compositions including sepiapterin, or a pharmaceutically acceptable salt thereof, and methods for the treatment of BH4-related disorders. In some embodiments, these compositions and methods result in an increase in plasma. CSF, and/or brain exposure of sepiapterin.
    Type: Application
    Filed: May 13, 2025
    Publication date: April 2, 2026
    Inventors: Neil SMITH, Jonathan REIS
  • Publication number: 20250195529
    Abstract: The present invention features compositions including sepiapterin, or a pharmaceutically acceptable salt thereof, and methods for the treatment of BH4-related disorders. In some embodiments, these compositions and methods result in an increase in plasma exposure of BH4.
    Type: Application
    Filed: March 4, 2025
    Publication date: June 19, 2025
    Inventors: Neil SMITH, Jonathan REIS
  • Patent number: 12329757
    Abstract: The present invention features compositions including sepiapterin, or a pharmaceutically acceptable salt thereof, and methods for the treatment of BH4-related disorders. In some embodiments, these compositions and methods result in an increase in plasma, CSF, and/or brain exposure of sepiapterin.
    Type: Grant
    Filed: March 31, 2023
    Date of Patent: June 17, 2025
    Assignee: PTC Therapeutics MP, Inc.
    Inventors: Neil Smith, Jonathan Reis
  • Patent number: 12283296
    Abstract: A spin-transfer torque (STT) magnetoresistive memory device includes a first electrode, a second electrode, and a magnetic tunnel junction located between the first electrode and the second electrode. The magnetic tunnel junction includes a reference layer having a fixed magnetization direction, a free layer stack, and a nonmagnetic tunnel barrier layer located between the reference layer and the free layer stack. The free layer stack has a total thickness of less than 2 nm, and contains in order, a proximal ferromagnetic layer located proximal to the nonmagnetic tunnel barrier layer, a first non-magnetic metal sub-monolayer, an intermediate ferromagnetic layer, a second non-magnetic metal sub-monolayer, and a distal ferromagnetic layer.
    Type: Grant
    Filed: January 14, 2022
    Date of Patent: April 22, 2025
    Assignee: Sandisk Technologies, Inc.
    Inventors: Tiffany Santos, Neil Smith
  • Patent number: 12257252
    Abstract: The present invention features compositions including sepiapterin, or a pharmaceutically acceptable salt thereof, and methods for the treatment of BH4-related disorders. In some embodiments, these compositions and methods result in an increase in plasma exposure of BH4.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: March 25, 2025
    Assignee: PTC Therapeutics MP, Inc.
    Inventors: Neil Smith, Jonathan Reis
  • Publication number: 20240122931
    Abstract: The invention features methods of treating a SARS-CoV-2 infection in a subject, the method comprising administering to the subject an effective amount of sepiapterin or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 9, 2022
    Publication date: April 18, 2024
    Inventors: Gene Chatman CLARK, Eleonora MEZZAROMA, Christopher RABENDER, Ross B. MIKKELSEN, Vasily YAKOVLEV, Neil SMITH
  • Publication number: 20240115572
    Abstract: The invention features methods of treating glioblastoma in a subject, the method comprising administering to the subject an effective amount of sepiapterin or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 9, 2022
    Publication date: April 11, 2024
    Inventors: Christopher RABENDER, Gene Chatman CLARK, Eleonora MEZZAROMA, Ross B. MIKKELSEN, Vasily YAKOVLEV, Neil SMITH
  • Publication number: 20230381181
    Abstract: The present invention features compositions including sepiapterin, or a pharmaceutically acceptable salt thereof, and methods for the treatment of BH4-related disorders. In some embodiments, these compositions and methods result in an increase in plasma, CSF, and/or brain exposure of sepiapterin.
    Type: Application
    Filed: March 31, 2023
    Publication date: November 30, 2023
    Inventors: Neil SMITH, Jonathan REIS
  • Publication number: 20230110351
    Abstract: The present invention features methods for treating Parkinson's disease using sepiapterin, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 22, 2021
    Publication date: April 13, 2023
    Inventor: Neil SMITH
  • Patent number: 11617752
    Abstract: The present invention features compositions including sepiapterin, or a pharmaceutically acceptable salt thereof, and methods for the treatment of BH4-related disorders. In some embodiments, these compositions and methods result in an increase in plasma, CSF, and/or brain exposure of sepiapterin.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: April 4, 2023
    Assignee: PTC Therapeutics MP, Inc.
    Inventors: Neil Smith, Jonathan Reis
  • Publication number: 20220362249
    Abstract: The invention features methods of reducing the blood phenylalanine concentration in a subject by administering sepiapterin, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 25, 2020
    Publication date: November 17, 2022
    Inventor: Neil SMITH
  • Patent number: 11462119
    Abstract: In one embodiment, the invention discloses a method for adapting educational content. The method comprises generating data for each of a plurality of students, the data pertaining to an aspect of the student's interaction with an educational system; combining the generated data to form a combined data set; analyzing the combined data set to identify clusters, each representing similar students according to a mathematical model; and adapting the educational system to provide a customized learning experience for a particular student based on an identified cluster.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: October 4, 2022
    Assignee: DreamBox Learning, Inc.
    Inventors: Benjamin W. Slivka, Lou Gray, Roy Leban, Nigel J. Green, Daniel R. Kerns, Neil Smith, Mickelle Weary, Cristopher Cook, Cheryl A. Dodge, Ronald Anthony Kornfeld
  • Publication number: 20220273661
    Abstract: The invention provides methods for treating radiation exposure in a subject by administering sepiapterin, tetrahydrobiopterin, or dihydrobiopterin.
    Type: Application
    Filed: August 5, 2020
    Publication date: September 1, 2022
    Inventors: Eleonora MEZZAROMA, Christopher RABENDER, Ross MIKKELSEN, Vasily YAKOVLEV, Neil SMITH
  • Publication number: 20220139435
    Abstract: A spin-transfer torque (STT) magnetoresistive memory device includes a first electrode, a second electrode, and a magnetic tunnel junction located between the first electrode and the second electrode. The magnetic tunnel junction includes a reference layer having a fixed magnetization direction, a free layer stack, and a nonmagnetic tunnel barrier layer located between the reference layer and the free layer stack. The free layer stack has a total thickness of less than 2 nm, and contains in order, a proximal ferromagnetic layer located proximal to the nonmagnetic tunnel barrier layer, a first non-magnetic metal sub-monolayer, an intermediate ferromagnetic layer, a second non-magnetic metal sub-monolayer, and a distal ferromagnetic layer.
    Type: Application
    Filed: January 14, 2022
    Publication date: May 5, 2022
    Inventors: Tiffany SANTOS, Neil SMITH
  • Patent number: 11276446
    Abstract: A magnetic memory device includes a first electrode, a second electrode, and a layer stack located between the first electrode and the second electrode. The layer stack includes a reference layer, a tunnel barrier layer, a free layer, and a magnetoelectric multiferroic layer including at least one crystalline grain. The magnetization of the magnetoelectric multiferroic layer may be axial, canted, or in-plane. For axial or canted magnetization of the magnetoelectric multiferroic layer, a deterministic switching of the free layer may be achieved through coupling with the axial component of magnetization of the magnetoelectric multiferroic layer. Alternatively, the in-plane magnetization of the magnetoelectric multiferroic layer may be employed to induce precession of the magnetization angle of the free layer.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: March 15, 2022
    Assignee: WESTERN DIGITAL TECHNOLOGIES, INC.
    Inventors: Bhagwati Prasad, Alan Kalitsov, Neil Smith
  • Publication number: 20220069200
    Abstract: A magnetic memory device includes a first electrode, a second electrode, and a layer stack located between the first electrode and the second electrode. The layer stack includes a reference layer, a tunnel barrier layer, a free layer, and a magnetoelectric multiferroic layer including at least one crystalline grain. The magnetization of the magnetoelectric multiferroic layer may be axial, canted, or in-plane. For axial or canted magnetization of the magnetoelectric multiferroic layer, a deterministic switching of the free layer may be achieved through coupling with the axial component of magnetization of the magnetoelectric multiferroic layer. Alternatively, the in-plane magnetization of the magnetoelectric multiferroic layer may be employed to induce precession of the magnetization angle of the free layer.
    Type: Application
    Filed: August 27, 2020
    Publication date: March 3, 2022
    Inventors: Bhagwati PRASAD, Alan KALITSOV, Neil SMITH
  • Publication number: 20220068337
    Abstract: A magnetic memory device includes a first electrode, a second electrode, and a layer stack located between the first electrode and the second electrode. The layer stack includes a reference layer, a tunnel barrier layer, a free layer, and a magnetoelectric multiferroic layer including at least one crystalline grain. The magnetization of the magnetoelectric multiferroic layer may be axial, canted, or in-plane. For axial or canted magnetization of the magnetoelectric multiferroic layer, a deterministic switching of the free layer may be achieved through coupling with the axial component of magnetization of the magnetoelectric multiferroic layer. Alternatively, the in-plane magnetization of the magnetoelectric multiferroic layer may be employed to induce precession of the magnetization angle of the free layer.
    Type: Application
    Filed: August 27, 2020
    Publication date: March 3, 2022
    Inventors: Bhagwati PRASAD, Alan KALITSOV, Neil SMITH
  • Patent number: 11264562
    Abstract: A magnetic memory device includes a first electrode, a second electrode, and a layer stack located between the first electrode and the second electrode. The layer stack includes a reference layer, a tunnel barrier layer, a free layer, and a magnetoelectric multiferroic layer including at least one crystalline grain. The magnetization of the magnetoelectric multiferroic layer may be axial, canted, or in-plane. For axial or canted magnetization of the magnetoelectric multiferroic layer, a deterministic switching of the free layer may be achieved through coupling with the axial component of magnetization of the magnetoelectric multiferroic layer. Alternatively, the in-plane magnetization of the magnetoelectric multiferroic layer may be employed to induce precession of the magnetization angle of the free layer.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: March 1, 2022
    Assignee: WESTERN DIGITAL TECHNOLOGIES, INC.
    Inventors: Bhagwati Prasad, Alan Kalitsov, Neil Smith
  • Patent number: 11238211
    Abstract: A system may use a machine-learned model to determine whether to classify a sequence of one or more words within a first document that is being edited as a candidate hyperlink based at least in part on context associated with the first document. In response to classifying the sequence of one or more words as the candidate hyperlink, the system may use the machine-learned model and based at least in part on the sequence of one or more words and the context to determine one or more candidate document to be hyperlinked from the sequence of one or more words. In response to receiving an indication of a second document being selected out of the one or more candidate documents, the system may modify the first document to associate the sequence of one or more words with a hyperlink to the second document.
    Type: Grant
    Filed: March 14, 2019
    Date of Patent: February 1, 2022
    Assignee: Google LLC
    Inventors: Jan van de Kerkhof, Balint Miklos, Amr Abdelfattah, Tobias Kaufmann, László Lukacs, Bjarke Ebert, Victor Anchidin, Brian Strope, Heeyoung Lee, Yun-hsuan Sung, Noah Constant, Neil Smith